Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 Carcinoma, Non-Small-Cell Lung 11 Neoplasm Metastasis 7 Brain Neoplasms 7 Rectal Neoplasms 6 Lung Neoplasms 6 Stomach Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Head and Neck Neoplasms 5 Urinary Bladder Neoplasms 4 Prostatic Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Esophageal Neoplasms 4 Uterine Cervical Neoplasms 3 Pancreatic Neoplasms 3 Melanoma 3 Glioblastoma 3 Colorectal Neoplasms 3 Colonic Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Neoplasms 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2 Inflammatory Breast Neoplasms 2 Glioma 2 Central Nervous System Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Adenocarcinoma 2 Vaginal Neoplasms 1

Interventions

Doxorubicin 8 Ifosfamide 6 Radiotherapy 4 Dacarbazine 3 Trabectedin 2 Filgrastim 2 pegfilgrastim 1 olaratumab 1 indolepropanol phosphate 1 anlotinib 1 Watchful Waiting 1 Tablets 1 Surgical Procedures, Operative 1 Rosuvastatin Calcium 1 Radiotherapy, Conformal 1 PM 01183 1 Observation 1 Neoadjuvant Therapy 1 Midazolam 1 Etoposide 1 Digoxin 1 Diathermy 1 Combined Modality Therapy 1 Chemotherapy, Adjuvant 1 ADI PEG20 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Leiomyosarcoma × Surgical Procedures, Operative × Clear all

NCT04031677 2026-05-22

STRASS2

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting

Leiomyosarcoma, Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡